Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - Ireland Inc. - Exhibit 10.1

AMENDMENT AGREEMENT TO
AGREEMENT AND PLAN OF
MERGER

THIS AMENDMENT AGREEMENT (the "Amendment
Agreement") is entered into as of January 31, 2007, among Ireland Inc., a
Nevada corporation (“Ireland”), CBI Acquisition, Inc., a Nevada
corporation and a wholly owned subsidiary of Ireland (“Sub”), Columbus
Brine Inc., a Nevada corporation (“CBI”), John T. Arkoosh, William Maghan
and Lawrence E. Chizmar Jr. (Messrs. Arkoosh, Maghan and Chizmar being
hereinafter referred to collectively as the “CBI Principals”).

WHEREAS:

A.     Ireland, Sub, CBI, and the CBI
Principals entered into an Agreement and Plan of Merger on December 14, 2007
(the “Original Agreement”); and

B.     The parties wish to amend the
Original Agreement in the manner provided for herein,

For good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, THE PARTIES HEREBY AGREE AS
FOLLOWS:

1.     Section 1.1(e) of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     (e)     As soon
as practicable after each condition to the obligations of Ireland, Sub and CBI
hereunder has been satisfied or waived, the Articles of Merger, in a form
properly completed and executed in accordance with the NRS (the “Articles of
Merger”) will be filed with the Secretary of State of the State of Nevada.
The Merger will become effective at the time and on the date the Articles of
Merger are so filed, provided that the filing date shall not be later than
February 22, 2008 unless a later date is otherwise agreed to, in writing, by
Ireland and CBI. The date and time when the Merger becomes effective is referred
to herein as the “Effective Time.”

2.     Section 1.3(a) of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     (a)     At the
Effective Time, all issued and outstanding shares of Common Stock of CBI
(“CBI Capital Stock”) shall be deemed converted into shares of Common
Stock of Ireland, $0.001 par value per share (“Ireland Common Stock”).
The maximum number of shares of Ireland Common Stock to be issued by Ireland in
connection with the Merger (rounded to the nearest whole share) (the “Maximum
Ireland Merger Shares”) shall be determined by dividing (i) $20,000,000 by
(ii) the Exchange Price. The “Exchange Price” shall be equal to $1.9157,
being equal to average daily closing price of the Ireland Common Stock as quoted
by the OTC Bulletin Board for the sixty (60) consecutive calendar days ending
prior to January 15, 2008

3.     Section 1.8(b) of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     (b)     Ireland
and CBI will coordinate and cooperate with respect to the timing of the CBI
Special Vote. Ireland shall prepare a Proxy Statement as described in Section
7.1 below, with the assistance and cooperation of CBI, which Proxy Statement
shall include such written disclosure to the CBI shareholders as shall be
required, in the reasonable determination of legal counsel to Ireland, to assure
that the issuance of the Merger Securities to the shareholders of CBI as
described in this Agreement is exempt from the registration requirements of the
Securities Act of 1933, as amended, and any applicable state or foreign law.
Unless extended by the mutual written agreement of Ireland and CBI, Ireland
agrees to use its best efforts to transmitted by overnight courier the Proxy
Statement to the shareholders of CBI by no later than February 1, 2008.

4.     Section 1.9 of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     Section
1.9 Filing of Merger Documents. As soon as practicable after the
requisite approval of the shareholders of CBI has been obtained as provided in
Section 1.8, and each other condition to the obligations of Ireland, Sub and CBI
hereunder, have been satisfied or waived, and not later than February 22, 2008,
unless extended by the mutual written agreement of Ireland and CBI, CBI and Sub
will deliver the Articles of Merger for filing with the Secretary of State of
the State of Nevada, and Ireland, Sub and CBI will take such other and further
actions as may be required by the NRS in connection with such filing and the
consummation of the Merger and Closing of this Agreement as described in Article
X.

5.     Section 5.8 of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     Section
5.8 No Additional Shares. Other than (a) shares issuable upon the proper
exercise of the Ireland Options or the Outstanding Ireland Warrants, (b) any
shares that Ireland may agree to issue in connection with the acquisition of any
new mineral claims forming part of the Red Mountain Project, as that term is
used in Ireland’s filings with the Commission, or (c) shares issuable pursuant
to the terms of this Agreement or the Ireland Merger Warrants, Ireland agrees
not to issue any additional shares from the date of this Agreement to the date
the Original Agreement, as amended is Closed or terminated.

6.     Section 7.4 of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     Section
7.4 Transmittal to Shareholders; Recommendation of CBI Board; CBI
Special Meeting. Ireland will cause the Proxy Statement to be transmitted
by overnight courier to CBI’s shareholders at the expense of Ireland as soon as
practicable, but not later than February 1, 2008, unless extended by the mutual
written agreement of Ireland and CBI, in accordance with applicable state law.
CBI will call a special meeting of the CBI shareholders (the “CBI Special
Meeting”) to be held as promptly as practicable, but not later than February
19, 2008 for the purpose of obtaining the shareholder approval of this Agreement
and the Merger and shall use all reasonable efforts to obtain such approval. CBI
shall coordinate and cooperate with Ireland with respect to the timing of the
CBI Special Meeting. CBI shall not change the date of the CBI Special Meeting
without the prior written 

consent of Ireland, nor shall CBI
adjourn the CBI Special Meeting without the prior written consent of Ireland,
unless such adjournment is due to the lack of a quorum or to receive additional
proxies to approve the Merger, in which case the Chairman of the CBI Special
Meeting shall announce at such meeting the time and place of the adjourned
meeting.

.

7.     Ireland agrees to complete its due
diligence investigations into the affairs of CBI by January 31, 2008. Ireland
further agrees that the condition precedent to Ireland and Sub’s obligation to
complete the Merger set out in Section 8.11 of the Original Agreement shall be
deemed to have been satisfied on January 31, 2008.

8.     If the Effective Date shall not have
occurred by February 22, 2008, then without regard for whether the Parties agree
to further extend the Effective Date, Sections 4.7 and 4.8 of the Original
Agreement shall be deemed to have been deleted from the Original Agreement, and
the parties, including the CBI Principals, shall have no obligations or
restrictions which otherwise would have been subject to such Sections.

9.     Article X of the Original Agreement
is amended by deleting it in its entirety, and replacing it with the
following:

ARTICLE X

CLOSING

     Unless
this Agreement shall have been terminated and the Merger shall have been
abandoned pursuant to a provision of Article XII hereof, a closing (the
“Closing”) will be held, after the satisfaction or waiver of the
conditions set forth in Articles VIII and IX, on or before February 22, 2008, at
the offices of Gunderson Law Firm, 5345 Kietzke Lane, Suite 200, Reno, NV 89511,
or such other date or place as may be agreed to, in writing, by Ireland and CBI.
At the date of the Closing (the “Closing Date”), the documents referred
to in Articles VIII and IX will be exchanged by the parties and, immediately,
thereafter, the Articles of Merger will be filed by CBI and Sub with the
Secretary of State of the State of Nevada.

10.     Section 12.1(b) of the Original
Agreement is amended by deleting it in its entirety, and replacing it with the
following:

     (b)     by
Ireland or CBI at any time after February 22, 2008 (or such later date as shall
have been agreed to in writing by Ireland and CBI) if the Merger for any reason
has not by such date become effective; provided, however, that this
provision shall not be available to any party whose wilful failure to fulfill
any obligation under this Agreement has been the cause of, or resulted in, the
failure of the Effective Time to occur on or before such date;

11.     Whereas Sub is referred to on the
signature page as “CBI Acquisition Corporation,” the parties agree that all
references to CBI Acquisition Corporation are references to Sub.

12.     The Condition to completion of the
Merger described in Section 8.12 of the Original Agreement is acknowledged by
Ireland and Sub to have been satisfied.

13.     The Original Agreement is deemed to
have been amended as of the day and year first above written and, in all other
respects, save and except as herein provided, the Original Agreement is hereby
confirmed and in full force and effect.

14.     This Amendment Agreement may be
signed by the parties in as many counterparts as may be necessary, each of which
so signed shall be deemed to be an original, and such counterparts together
shall constitute one and the same instrument and notwithstanding the date of
execution shall be deemed to bear the date first set forth above.

IN WITNESS WHEREOF the parties hereto have executed this
Amendment Agreement as of the day and year first above written.

	 	IRELAND INC. 
	 	By: /s/ Douglas D.G. Birnie

	 	Title: President 
	 	  
	 	CBI ACQUISITION, INC. 
	 	By: /s/ Douglas D.G. Birnie

	 	Title: President 
	 	  
	 	COLUMBUS BRINE INC. 
	 	By: /s/ John T. Arkoosh 
	 	Title: President 
	 	  
	 	/s/
      John T. Arkoosh 
	 	JOHN T. ARKOOSH 
	 	  
	 	/s/
      William Maghan 
	 	WILLIAM MAGHAN 
	 	  
	 	/s/
      Lawrence E. Chizmar 
	 	LAWRENCE E. CHIZMARFiled by Automated Filing Services Inc. (604) 609-0244 - NextGen Bioscience Inc. - Exhibit 10.1

EXHIBIT 10.1

ASSET PURCHASE AGREEMENT

THIS AGREEMENT effective as of 31st January,
2008.

BETWEEN:

OXON LIFE SCIENCE LIMITED., a
company incorporated pursuant to the laws of Nevis, British West Indies and
having an address at Donegan, Zetlands, Nevis, St Kitts & Nevis, West
Indies

(the “Seller”)

AND:

NEXTGEN BIOSCIENCE INC., a
company incorporated pursuant to the laws of the State of Nevada and having a
business address at 4th Floor, 36 Spital Square, London, England, E1
6DY

(the “Buyer”)

WHEREAS:

A.      The Seller is the owner of
certain assets and undertakings relating to the development of therapies for the
treatment of certain types of cancer; 

B.      The Buyer desires to purchase
from the Seller and the Seller desires to sell and assign to the Buyer certain
intellectual property assets of the Seller in exchange for shares of the Buyer
on the terms and subject to the conditions of this Agreement; and

C.      In contemplation of the
execution of this Agreement, the Seller has filed a patent application relating
to the intellectual property assets contemplated hereby with the European Patent
Office in the name of the Buyer.

NOW THEREFORE, in consideration of the mutual promises
of the parties hereto, and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, it is mutually agreed by and
between the parties hereto as follows:

ARTICLE 1

DEFINITIONS AND INTERPRETATION

Definitions

1.1      In this Agreement, including
the recitals and schedules, the following words and phrases have the following
meanings:

(a)     
“Affiliate” in respect of a Person, means any other Person that, directly
or indirectly, through one or more intermediaries, controls, is controlled by or
is under common control with, such first Person where “control” means, with
respect to the relationship between or among two or more Persons, the
possession, directly or indirectly or as trustee, personal representative or
executor, of the power to direct or cause the direction of the affairs or
management of a Person, whether through the ownership of voting securities, as
trustee, personal representative or executor, by contract, credit arrangement or
otherwise, including, without limitation, the ownership, directly or indirectly,
of securities having the power to elect a majority of the board of directors or
similar body governing the affairs of such Person;

(b)     
“Assets” means all property and assets set forth in Schedule A hereto,
which property and assets include, without limitation, the Contracts, the
Intellectual Property and the Permits and Licenses;

(c)     
“Business Day” means any day other than a Saturday, Sunday or public
holiday in London, England;

(d)     
“Closing” means the completion of the purchase and sale of the Assets on
the terms and subject to the conditions contained in this Agreement by the Buyer
and the Seller respectively;

(e)     
“Closing Date” means the 1st day of February, 2008, or such
other day as agreed to in writing between the Parties on which the Closing is to
occur;

(f)     
“Disclosure Schedule” means the disclosure schedule attached as Schedule
B hereto. The Disclosure Schedule will be arranged in sections corresponding to
the numbered and lettered sections contained in this Agreement and the
disclosure in any section qualifies other sections in this Agreement only to the
extent that such disclosure specifically references the fact that it also
qualifies or applies to such other specified sections;

(g)     
“Encumbrance” means any lien, claim, charge, pledge, hypothecation,
security interest, mortgage, title retention agreement, option, assignment,
license or other encumbrance or adverse claim of any nature or kind
whatsoever;

(h)     
“Exchange Act” means the United States Securities Exchange Act of 1934,
as amended;

(i)     
“Intellectual Property” means all rights in and to patents and patent
applications, registered or unregistered trademarks, service marks, and
trademark or service mark registrations and applications, trade names, logos,
designs, Internet domain names, slogans and general intangibles of like nature,
together with all goodwill relating to the foregoing, copyrights, copyright
registrations, renewals and applications, Software, licenses, agreements and all
other proprietary rights, which relate to the Assets;

(j)     
“Party” means each party to this Agreement individually and
“Parties” mean each Party collectively;

(k)     
“Person” is to be broadly interpreted and includes an individual, a
partnership, a corporation, a limited liability company, an association, a joint
stock company, a trust, a joint venture, an unincorporated organization or
association, or a Governmental Entity;

(l)     
“Purchase Price” means the Shares of the Buyer to be issued to the Seller
at Closing in consideration for the purchase of the Assets; 

(m)     
“Purchaser’s Solicitors” means Lang Michener LLP;

(n)     
“SEC” means the United States Securities and Exchange Commission; (o)
“Securities Act” means the United States Securities Act of 1933, as
amended; (p) “Shares” means 22,000,000 shares of the Buyer’s Common
Stock;

Schedules

1.2      The following schedules are
attached to, form part of, and are hereby incorporated by reference into this
Agreement:

Schedule A – Description of
Assets

Schedule B – Disclosure
Schedule

Schedule C – Assignment of
Intellectual Property

ARTICLE 2

SALE AND TRANSFER OF ASSETS; CLOSING

2.1      Sale of Assets.
Subject to the terms and conditions of this Agreement, and in reliance upon
the representations, warranties, covenants and agreements contained herein, at
the Closing, the Seller shall sell, convey, assign and transfer the Assets to
the Buyer, and the Buyer shall purchase the Assets from the Seller.

2.2      Consideration. In
consideration of the sale, transfer and assignment to the Buyer of the Assets,
at the Closing, the Buyer shall issue and deliver to the Seller the Shares,
which Shares shall be subject to any increase or decrease in the Buyer’s share
capital prior to Closing as a result of any subdivision or consolidation of the
Buyer’s share capital.

2.3      The Closing. The
Closing shall take place on the Closing Date at the offices of the Buyer or such
other place as the parties may agree in writing. 

ARTICLE 3

REPRESENTATIONS AND WARRANTIES OF THE SELLER 

To induce the Buyer to execute, deliver and perform this
Agreement, and in acknowledgement of the Buyer’s reliance on the following
representations and warranties (in addition to any other representations and
warranties included in this Agreement), the Seller represents and warrants to
the Buyer as follows as of the date hereof and as of the Closing Date:

3.1      Organization. The
Seller is a corporation duly organized, validly existing and in good standing
under the applicable laws of Nevis, West Indies with the power and authority to
conduct its business as it is now being conducted and to own its assets.

3.2      Power and Authority.
The Seller has the power and authority to execute, deliver, and carry out
its obligations under the Agreement and any other agreements and instruments to
be executed and delivered by it in connection with the transactions contemplated
hereby, and the Seller has taken all necessary action to authorize the execution
and delivery of this Agreement and such other agreements and instruments and the
consummation of the transactions contemplated hereby, including but not limited
to the receipt of all necessary regulatory approvals. This Agreement is, and the
other agreements and instruments to be executed and delivered by the Seller in
connection with the transactions contemplated hereby, when such other agreements
and instruments are executed and delivered, shall be the valid and legally
binding obligations of the Seller enforceable against the Seller in accordance
with their respective terms.

3.3      Title to Assets. The
Seller is the owner of all of the Assets free and clear of any and all
Encumbrances. Without limiting the generality of the foregoing, neither the
Seller’s Affiliates, consultants or clients, nor any employees of the Seller,
own or possess any of the Assets (including, without limitation, any
Intellectual Property) or any legal or beneficial interest in the Assets.

3.4      No Rights to Purchase
Assets. There is no agreement, contract, option, commitment or other right
in favour of, or held by, any person for the purchase of the Assets or any
interest therein from the Seller.

3.5      No Conflict. Neither
the execution and delivery of this Agreement and the other agreements and
instruments to be executed and delivered in connection with the transactions
contemplated hereby, nor the consummation of the transactions contemplated
hereby, will violate or conflict with: 

(a)      any
law, regulation, ordinance, governmental restriction, order, judgment or decree
applicable to the Seller; 

(b)      any
provision of any charter, bylaw or other governing or organizational instrument
of the Seller; or 

(c)      any
mortgage, indenture, license, instrument, trust, contract, agreement, or other
commitment or arrangement to which the Seller is a party or by which the Seller
is bound.

3.6      Litigation. There are
no actions, suits, claims, applications, complaints or investigations,
directive, or notice of defect or non-compliance in any court or before any
arbitrator or before or by any regulatory body, board, tribunal, administrative
licensing or regulatory agency, body or office, or governmental department or
governmental or non-governmental body issued or pending or, to the Seller’s
knowledge, threatened by or against the Seller, or related to its business, the
Assets or affecting the business or the operations of the business or the
transactions contemplated by this Agreement and to the Seller’s knowledge there
is not factual or legal basis which could give rise to any such actions, suit,
proceeding, claim, application, complaint, investigation, directive or notice of
defect or non-compliance. 

3.7      Intellectual
Property.

(a)      The
Seller owns or has the valid right to use all of its Intellectual Property.

(b)      The
Intellectual Property owned or used by the Seller is free and clear of all
liens, charges, Encumbrances or other restrictions on transfer. The Seller is
registered with all applicable governmental agencies as the sole owner of record
for each application and registration listed on Schedule A.

(c)      The
Seller owns no trademarks or software related to the Assets in any form. The
patent registrations listed in Schedule A are valid and subsisting, in full
force and effect, and have not been cancelled, expired, or abandoned. There is
no pending or threatened opposition, interference or cancellation proceeding
before any court or registration authority in any jurisdiction against such
registrations or against any of the Intellectual Property licensed to the Seller
pursuant to the License Agreements (as defined in the next paragraph).

(d)     
Schedule A attached hereto sets forth a complete and accurate list of all
agreements pertaining to the use of, or granting any right to use or practice
any rights under, the Intellectual Property, whether the Seller is the licensee,
licensor or user thereunder and whether written, oral, express or implied, and
any written settlements or consents relating to any Intellectual Property and
covenants not to sue (collectively, the “License Agreements”), indicating for
each the title, the parties, date executed, and the Intellectual Property
covered thereby. Except as set forth in Schedule B, there are no settlements,
consents, judgments, or orders or other agreements which restrict any of the
Seller’s rights to use any of the Intellectual Property or permit third parties
to use any Intellectual Property which would otherwise infringe any of the
Seller’s Intellectual Property.

(e)      To
the best of the Seller’s knowledge, no third party is misappropriating,
infringing, diluting, or violating any of the Intellectual Property owned by,
assigned or licensed to the Seller, and no such claims are pending against a
third party by the Seller.

3.8      Investor Representations.
The Seller acknowledges and agrees that the Shares will be offered and sold
to the Seller without being registered under the Securities Act and will be
issued to the Seller in accordance with Rule 903 of Regulation S of the
Securities Act in an “offshore transaction” within the meaning of
Regulation S based on the representations and warranties of the Seller in this
Agreement. As such, the Seller further acknowledges and agrees that all Shares
will, upon issuance, be “restricted securities” within the meaning of the
Securities Act.

3.9      Agreement Regarding
Resale. The Seller agrees to resell the Shares only in accordance with the
provisions of Regulation S of the Securities Act, pursuant to registration under
the Securities Act, or pursuant to an available exemption from registration
pursuant to the Securities Act, and otherwise in accordance with all applicable
state securities laws and the laws of any other jurisdiction. The Seller agrees
that the Buyer may require the opinion of legal counsel reasonably acceptable to
the Buyer in the event of any offer, sale, pledge or transfer of any of the
Shares by the Seller pursuant to an exemption from registration under the
Securities Act.

3.10      Prohibition Against
Hedging Transactions. The Seller agrees not to engage in hedging
transactions with regard to the Shares unless in compliance with the Securities
Act.

3.11      Right of Company to
Refuse Transfer. The Seller agrees that the Buyer will refuse to register
any transfer of the Shares not made in accordance with the provisions of
Regulation S of the Securities Act, pursuant to registration under the
Securities Act, pursuant to an available exemption from registration, or
otherwise pursuant to this Agreement. 

3.12      No Obligation to
Register. The Seller acknowledges that the Buyer has not agreed and has no
obligation to register the resale of the Shares under the Securities Act.

3.13      Share Certificates.
The Seller acknowledges and agrees that any and all certificates representing
the Shares will be endorsed with the following legend pursuant to Regulation S
of the Securities Act or such similar legend as deemed advisable by legal
counsel for the Buyer to ensure 

compliance with Regulation S of the Securities Act and to
reflect the status of the Shares as restricted securities: 

  “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN
    AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933,
    AS AMENDED (THE “U.S. SECURITIES ACT”) OR UNDER THE STATE SECURITIES
    LAWS OF ANY OF THE UNITED STATES. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES,
    AGREES FOR THE BENEFIT OF THE CORPORATION THAT SUCH SECURITIES MAY BE OFFERED,
    SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE
    UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATIONS UNDER THE U.S. SECURITIES
    ACT, (C) WITHIN THE UNITED STATES IN ACCORDANCE WITH THE EXEMPTION FROM REGISTRATION
    UNDER THE U.S. SECURITIES ACT PROVIDED BY RULES 144 OR 144A THEREUNDER, IF
    AVAILABLE, AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS, OR
    (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES
    ACT OR APPLICABLE STATE SECURITIES LAWS, AND, IN THE CASE OF (C) OR (D) THE
    SELLER HAS FURNISHED TO THE CORPORATION AN OPINION TO SUCH EFFECT FROM COUNSEL,
    OF RECOGNIZED STANDING REASONABLY SATISFACTORY TO THE CORPORATION PRIOR TO
    SUCH OFFER, SALE OR TRANSFER.”

3.14      Issuance of Shares.
The Seller further represents and warrants to the Buyer as follows, and
acknowledges that the Buyer is relying upon such covenants, representations and
warranties in connection with the issue of the Shares to the Seller:

(a)      the
Seller is not a “U.S. Person” as defined in Regulation S of the
Securities Act and is not acquiring the Shares for the account or benefit of a
U.S. Person;

(b)      the
Seller was not in the United States at the time the offer to purchase the Shares
was received or this Agreement was executed; 

(c)      The
Seller has not purchased the Shares as a result of any form of general
solicitation or general advertising, including advertisements, articles, notices
or other communications published in any newspaper, magazine or similar media or
broadcast over radio, television or other form of telecommunications, or any
seminar or meeting whose attendees have been invited by general solicitation or
general advertising;

(d)      the
Seller has such knowledge, sophistication and experience in business and
financial matters such that it is capable of evaluating the merits and risks of
the investment in the Shares. The Seller has evaluated the merits and risks of
an investment in the Shares. The Seller can bear the economic risk of this
investment, and is able to afford a complete loss of this investment;

(e)      the
Seller acknowledges that the Buyer is in the early stages of development of its
business and the Buyer’s success is subject to a number of significant risks,
including the risk that the Buyer will not be able to finance its plan of
operations. The Seller further acknowledges that (i) the Buyer has limited cash
and working capital, (ii) the Buyer will have to raise additional capital in
order to finance its plan of operations which capital may be raised by the issue
of additional shares of its common stock which will result in dilution to the
Seller, and (iii) the 

Buyer has no arrangements for any
financing in place and there is no assurance that any financing will be
completed;

(f)      the
Shares will be acquired by the Seller for investment for the Seller's own
account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and that the Seller has no present intention
of selling, granting any participation in, or otherwise distributing the same in
the United States or to any U.S. Person. The Seller does not have any contract,
undertaking, agreement or arrangement with any person to sell, transfer or grant
participations to such person or to any third person, with respect to any of the
Shares;

(g)      the
Seller has been afforded access to information about the Buyer and the Buyer’s
financial condition, results of operations, business, properties, management and
prospects sufficient for it to evaluate an investment in the Shares. The Seller
further represents that it has had an opportunity to ask questions and receive
answers from representatives of the Buyer regarding the terms and conditions of
the offerings completed by the Buyer and the business, properties, prospects and
financial condition of the Buyer, each as is necessary to evaluate the merits
and risks of investing in the Shares. The Seller believes it has received all
the information it considers necessary or appropriate for deciding whether to
purchase the Shares. The Seller has had full opportunity to discuss this
information with the Seller’s legal and financial advisers prior to execution of
this Agreement;

(h)      the
Seller acknowledges that the Buyer will rely on these representations in
completing the issuance of the Shares to the Seller;

(i)      the
Seller acknowledges that the offering of the Shares by the Buyer has not been
reviewed by the United States Securities and Exchange Commission or any state
securities regulatory authority;

(j)      this
Agreement has been duly authorized, validly executed and delivered by the
Seller; and

(k)      the
Seller has satisfied itself as to the full observance of the laws of its
jurisdiction in connection with the purchase of the Shares and the execution of
this Agreement, including (i) the legal requirements within its jurisdiction of
incorporation or residence of the Seller for the purchase of the Shares; (ii)
any local or foreign exchange restrictions applicable to such purchase; (iii)
any governmental or other consents that may need to be obtained; (iv) the income
tax and other tax consequences, if any, that may be relevant to an investment in
the Shares; and (v) any restrictions on transfer applicable to any disposition
of the Shares imposed by the jurisdiction in which the Seller is incorporated or
resident.

3.15      Disclosure. No
representation, warranty, or statement made by the Seller in this Agreement or
in any document or certificate furnished or to be furnished to the Buyer
pursuant to this Agreement contains or will contain any untrue statement or
omits or will omit to state any fact necessary to make the statements contained
herein or therein not misleading. The Seller has disclosed to the Buyer all
facts known or reasonably available to the Seller that are material to the use
of the Assets.

3.16      Truth at Closing. All
of the representations, warranties and agreements made by the Seller contained
in this Agreement shall be true and correct and in full force and effect as of
the date hereof and as of the Closing Date.

ARTICLE 4

REPRESENTATIONS AND WARRANTIES OF BUYER

To induce the Seller to execute, deliver and perform this
Agreement, and in acknowledgement of the Seller’s reliance on the following
representations and warranties, the Buyer hereby represents and warrants to the
Seller as follows as of the date hereof and as of the Closing Date:

4.1      Organization. The
Buyer is a corporation duly incorporated, validly existing and in good standing
under the laws of the State of Nevada, with the power and authority to conduct
its business as it is now being conducted and to own and lease its properties
and assets.

4.2      Power and Authority.
The Buyer has the power and authority to execute, deliver, and perform this
Agreement and the other agreements and instruments to be executed and delivered
by it in connection with the transactions contemplated hereby, and the Buyer has
taken all necessary action to authorize the execution and delivery of this
Agreement and such other agreements and instruments and the consummation of the
transactions contemplated hereby. This Agreement is, and, when such other
agreements and instruments are executed and delivered, the other agreements and
instruments shall be, the valid and legally binding obligations of the Buyer,
enforceable in accordance with their respective terms.

4.3      Broker’s or Finder’s Fees.
The Buyer has not authorized any person to act as broker, finder, or in any
other similar capacity in connection with the transactions contemplated by this
Agreement.

4.4      No Conflict. Neither
the execution and delivery by the Buyer of this Agreement and of the other
agreements and instruments to be executed and delivered by the Buyer in
connection with the transactions contemplated hereby or thereby, nor the
consummation by the Buyer of the transactions contemplated hereby, will violate
or conflict with: (a) any law, regulation, ordinance, governmental restriction,
order, judgment or decree applicable to the Buyer; or (b) any provision of any
charter, bylaw, or other governing or organizational instrument of the
Buyer.

4.5      Capitalization – the
authorized capital of the Buyer consists of 100,000,000 shares of common stock
and 5,000,000 shares of preferred stock;

4.6      Truth at Closing. All
of the representations, warranties, and agreements of the Buyer contained in
this Agreement shall be true and correct and in full force and effect as of the
date hereof and as of the Closing Date, except as otherwise contemplated
hereby.

ARTICLE 5

COVENANTS OF THE SELLER PRIOR TO CLOSING

5.1      Conduct of Business.
From the date hereof until the Closing Date, the Seller will use its
commercially reasonable efforts to:

	 	(a) 	
      preserve the Assets;

	 	 	 
	 	(b) 	
      use reasonable commercial efforts to preserve and prevent
      any damage to, destruction or loss of any of the Assets, whether or not
      such assets are covered by insurance;

	 	(c) 	
      take all action necessary to prevent the loss,
      cancellation, abandonment, forfeiture or expiration of any Intellectual
      Property;

	 	 	 
	 	(d) 	
      give to the Buyer, the Buyer’s Solicitors, the Buyer’s
      advisors and other representatives of the Buyer, full access during normal
      business hours to management, properties, books, contracts, commitments
      and records of the Seller;

	 	 	 
	 	(e) 	
      furnish the Buyer with all information concerning the
      Assets as the Buyer may reasonably request;

	 	 	 
	 	(f) 	
      promptly advise the Buyer in writing of any material
      change in the condition of the Assets;

	 	 	 
	 	(g) 	
      provide the Buyer with all information required to enable
      the Buyer to prepare and file all notices and applications required to be
      filed for the purposes of obtaining of any regulatory consent which is
      required in connection with the transactions contemplated
herein;

	 	 	 
	 	(h) 	
      keep in full force and effect any insurance;

	 	 	 
	 	(i) 	
      not sell, agree to sell or otherwise dispose of or
      license, pledge or encumber any of the Assets;

	 	 	 
	 	(j) 	
      not sell, transfer, license, sublicense or otherwise
      dispose of any Intellectual Property of the Seller, or amend or modify any
      existing agreements or rights with respect to any Intellectual Property
      of, or used by, the Seller, and in particular in no event shall the Seller
      license on an exclusive basis or sell any Intellectual Property of the
      Seller;

	 	 	 
	 	(k) 	
      not waive the benefits of, agree to modify in any manner,
      terminate, release any person from or knowingly fail to enforce any
      confidentiality or similar agreement to which the Seller is a party or of
      which the Seller is a beneficiary; and

	 	 	 
	 	(l) 	
      not take, or agree in writing or otherwise to take, any
      of the actions described in (a) through (k) above, or any action which
      would make any of the representations or warranties of the Seller in this
      Agreement untrue or incorrect in any material respect or prevent the
      Seller from performing its covenants hereunder or result in any of the
      conditions to the Agreement set forth herein not being
  satisfied.

5.2      Required Approvals. As
promptly as practicable after the date of this Agreement, the Seller shall make
all filings required by applicable law to be made by it in order to consummate
the transactions contemplated hereby. The Seller shall:

(a)     
cooperate with the Buyer with respect to all filings that the Buyer elects to
make or is required by law to make in connection with the transactions
contemplated hereby, and 

(b)     
cooperate with the Buyer in obtaining any consents contemplated hereby.

5.3      Necessary Steps. The
Seller will to take all actions, steps and proceedings that are necessary or
desirable to approve or authorize, or to validly and effectively undertake, the
execution, delivery and performance of this Agreement, the other instruments and
agreements contemplated hereby and the completion of the transactions
contemplated hereby.

ARTICLE 6

COVENANTS OF THE BUYER PRIOR TO CLOSING

6.1      Ordinary Course of
Business. The Buyer covenants and agrees with the Seller that following the
execution of this Agreement and until Closing the Buyer will conduct its
business in the ordinary and normal course thereof.

6.2      Necessary Steps. The
Buyer will take all actions, steps and proceedings that are necessary or
desirable to approve or authorize, or to validly and effectively undertake, the
execution, delivery and performance of this Agreement and the completion of the
transactions contemplated hereby.

ARTICLE 7

CONDITIONS TO THE SELLER’S OBLIGATIONS

The obligations of the Seller to be performed hereunder shall
be subject to the satisfaction (or waiver by the Seller) at or prior to the
Closing Date of each of the following conditions:

7.1      Representations and
Warranties; Performance. The Buyer shall have performed and complied in all
material respects with the covenants and agreements contained in this Agreement
required to be performed and complied with by it at or prior to the Closing Date
and shall have delivered all documents required to be delivered at Closing as
contemplated hereby, the representations and warranties of the Buyer set forth
in this Agreement shall be true and correct in all respects as of the date
hereof and as of the Closing Date as though made at and as of the Closing Date
(except as otherwise expressly contemplated by this Agreement), and the
execution and delivery of this Agreement by the Buyer and the consummation of
the transactions contemplated hereby shall have been duly and validly authorized
by the Buyer’s Board of Directors, and the Seller shall have received a
certificate to that effect signed by a senior officer of the Buyer.

7.2      Litigation. No
litigation shall be threatened or pending against the Buyer or the Seller that,
in the reasonable opinion of counsel for the Seller, could result in the
restraint or prohibition of any such party, or the obtaining of damages or other
relief from such party, in connection with this Agreement or the consummation of
the transactions contemplated hereby.

ARTICLE 8

CONDITIONS TO THE BUYER’S OBLIGATIONS

The obligations of the Buyer to be performed hereunder shall be
subject to the satisfaction (or the waiver by the Buyer) at or prior to the
Closing Date of each of the following conditions:

8.1      Representations and
Warranties; Performance. The Seller shall have performed and complied in all
respects with the covenants and agreements contained in this Agreement required
to be performed and complied with by it at or prior to the Closing Date and
shall have delivered all documents required to be delivered at Closing as
contemplated hereby, the representations and warranties of the Seller set forth
in this Agreement shall be true and correct in all material respects as of the
date hereof and as of the Closing Date as though made at and as of the Closing
Date (except as otherwise expressly contemplated by this Agreement), and the
execution and delivery of this Agreement by the Seller and the 

consummation of the transactions contemplated hereby shall have
been duly and validly authorized by the Seller’s Board of Directors, and the
Buyer shall have received a certificate to that effect signed by a senior
officer of the Buyer.

8.2      No litigation. No
litigation shall be threatened or pending against the Buyer or the Seller that,
in the reasonable opinion of counsel for the Buyer, could result in the
restraint or prohibition of any such party, or the obtaining of damages or other
relief from such party, in connection with this Agreement or the consummation of
the transactions contemplated hereby.

8.3      Due Diligence. The
Buyer shall have completed its due diligence review of the Assets and shall have
been satisfied with the findings thereof.

8.4      No Material Adverse
Change. From the date hereof to the Closing Date, there shall have been no
material adverse change to the Assets, taken as a whole, as determined by the
Buyer in its sole discretion.

ARTICLE 9

CLOSING

9.1      Deliveries by the Seller.
On Closing, the Seller shall deliver or cause to be delivered to the Buyer
the following:

	 	(a) 	
      all bills of sale, assignments and transfers, in form and
      content reasonably satisfactory to the solicitors for the Buyer and the
      Seller, appropriate to effectively vest good and marketable title to the
      Assets in the Buyer to the extent contemplated by this Agreement, and
      immediately registrable in all places where registration of such
      instruments is required;

	 	 	 
	 	(b) 	
      all instruments of assignment of Intellectual Property
      appropriate to effectively vest good and marketable title to the
      Intellectual Property in the Buyer to the extent contemplated by this
      Agreement, and immediately registrable in all places where registration of
      such instruments is required;

	 	 	 
	 	(c) 	
      any other documents the Buyer may reasonably require to
      transfer to the Buyer on the Closing Date good and marketable title to the
      Assets, free and clear of all Encumbrances;

	 	 	 
	 	(d) 	
      a certificate of an officer of the Seller certifying the
      truth and accuracy of the representations and warranties and compliance
      with covenants of the Seller in this Agreement, each as of the Closing
      Date;

	 	 	 
	 	(e) 	
      direction from the Seller as to the manner of
      registration of the Shares, and in the event such shares are to be
      registered in a name other than the Seller, an Investment Agreement from
      such registered shareholder in such form as may be required by the Buyer
      and the Buyer’s solicitors, acting reasonably;

	 	 	 
	 	(f) 	
      certified copy of the resolutions of the directors of the
      Seller approving this Agreement and the transactions contemplated
      hereby;

	 	 	 
	 	(g) 	
      all books and records relating to the Assets;
  and

	 	(h) 	
      if the parties:

	 	 	 	 
	 		(i) 	
      settle on a mutually acceptable form of Closing agenda
      prior to the Closing Date, then such other Closing documents as are listed
      on that Closing agenda as Closing documents to be delivered by the Seller;
      or

	 	 	 	 
	 		(ii) 	
      choose not to or are unable to settle on a mutually
      acceptable form of Closing agenda prior to the Closing Date, then such
      other materials that are, in the opinion of the Seller and the Buyer
      acting reasonably, required to be delivered by either the Seller or the
      Buyer in order for it to have met its obligations under this
    Agreement.

9.2      Deliveries by Buyer.
On Closing, the Buyer shall deliver or cause to be delivered to the Seller
the following:

	 	(a) 	
      certified copy of the resolutions of the directors of the
      Buyer approving this Agreement and all of the transactions contemplated
      hereunder;

	 	 	 	 
	 	(b) 	
      share certificate(s) representing the Shares issued in
      the name of the Seller, or as directed by the Seller, endorsed with the
      legends contemplated by this Agreement;

	 	 	 	 
	 	(c) 	
      a certificate of an officer of the Buyer certifying the
      truth and accuracy of the representations and warranties and compliance
      with covenants of the Buyer in this Agreement, each as of the Closing
      Date;

	 	 	 	 
	 	(d) 	
      if the parties:

	 	 	 	 
	 		(i) 	
      settle on a mutually acceptable form of Closing agenda
      prior to the Closing Date, then such other Closing documents as are listed
      on that Closing agenda as Closing documents to be delivered by the Buyer;
      or

	 	 	 	 
	 		(ii) 	
      choose not to or are unable to settle on a mutually
      acceptable form of Closing agenda prior to the Closing Date, then such
      other materials that are, in the opinion of the Seller and the Buyer
      acting reasonably, required to be delivered by the Buyer in order for it
      to have met its obligations under this Agreement.

ARTICLE 10

COVENANTS OF THE SELLER AND THE BUYER FOLLOWING
CLOSING

10.1      Allocation of Purchase
Price; Transfer Taxes.

(a)     
Consistent with applicable tax rules, the Buyer shall allocate the Purchase
Price to the Assets. The Buyer shall prepare and file, in a timely fashion,
forms in a manner consistent with such allocation with the relevant tax
authority. All tax returns and reports filed or prepared by the Buyer and/or the
Seller with respect to the transactions contemplated by this Agreement shall be
consistent with the allocation made by the Buyer under this §10.1(a) . 

(b)      All
sales, transfer, and similar taxes and fees (including all recording fees, if
any) incurred in connection with this Agreement and the transactions
contemplated hereby shall be 

borne by the Seller and the Seller
shall file all necessary documentation with respect to such taxes.

10.2      Further Assurances.
Subject to the terms and conditions of this Agreement, each party agrees to
use all of its reasonable efforts to take, or cause to be taken, all actions and
to do or cause to be done, all things necessary and proper or advisable to
consummate and make effective the transactions contemplated by this Agreement
(including the execution and delivery of such further instruments and documents)
as the other party may reasonably request.

10.3      Nondisclosure of
Proprietary Data. The Parties shall hold confidential and in a fiduciary
capacity for the benefit of each other all secret or confidential information,
knowledge or data relating to the other or any of their affiliated companies,
and their respective businesses, which shall not be or become public knowledge.
Neither Party, without the prior written consent of the other, or as may
otherwise be required by law or legal process, shall communicate or divulge
either before or after the Closing Date any such information, knowledge or data
to anyone other than the other Party and those designated by the other Party in
writing.

ARTICLE 11

SURVIVAL AND INDEMNITY

11.1      Survival of
Representations, Warranties, Etc. Each of the representations, warranties,
agreements, covenants and obligations herein is material and shall be deemed to
have been relied upon by the other party or parties and shall survive
indefinitely after the date hereof and after the Closing and shall not merge in
the performance of any obligation by any party hereto. All rights to
indemnification contained in this Agreement shall survive the Closing
indefinitely.

11.2      Indemnification by the
Seller and Buyer. The parties shall indemnify, defend, and hold harmless
each other, and each other’s representatives, stockholders, controlling persons
and affiliates, at, and at any time after, the Closing, from and against any and
all demands, claim, actions, or causes of action, assessments, losses, damages
(including incidental and consequential damages), liabilities, costs, and
expenses, including reasonable fees and expenses of counsel, other expenses of
investigation, handling, and Litigation, and settlement amounts, together with
interest and penalties asserted against, resulting to, imposed upon, or incurred
by a party (the “Indemnified Party”), directly or indirectly, by reason
of, resulting from, or arising in connection with: (i) any breach of any
representation, warranty, or agreement of the other party (the “Indemnifying
Party”) contained in or made pursuant to this Agreement, including the
agreements and other instruments contemplated hereby; (ii) any breach of any
representation, warranty, or agreement of the Indemnifying Party contained in or
made pursuant to this Agreement, including the agreements and other instruments
contemplated hereby, as if such representation or warranty were made on and as
of the Closing Date; (iii) any claim by any person for brokerage or finder’s
fees or commissions or similar payments based upon any agreement or
understanding alleged to have been made by any such person with the Indemnifying
Party in connection this Agreement or any of the transactions contemplated
hereby; and (iv) to the extent not covered by the foregoing, any and all
demands, claims, actions or causes of action, assessments, losses, damages,
liabilities, costs, and expenses, including reasonable fees and expenses of
counsel, other expenses of investigation, handling, and Litigation and
settlement amounts, together with interest and penalties, incident to the
foregoing.

The remedies provided in this §11.2 will not be exclusive of or
limit any other remedies that may be available to the either party to this
Agreement.

ARTICLE 12

TERMINATION

12.1      Termination. This
Agreement may be terminated at any time prior to the Closing Date:

(a)      by
mutual written consent of the Seller and the Buyer;

(b)      by
either the Seller or the Buyer if (i) there shall have been a material breach of
any representation, warranty, covenant or agreement set forth in this Agreement,
on the part of the Buyer, in the case of a termination by the Seller, or on the
part of the Seller, in the case of a termination by the Buyer, which breach
shall not have been cured, in the case of a representation or warranty, prior to
Closing or, in the case of a covenant or agreement, within ten (10) business
days following receipt by the breaching party of notice of such breach, or (ii)
any permanent injunction or other order of a court or other competent authority
preventing the consummation of the transactions contemplated hereby shall have
become final and non-appealable; or

(c)      by
either the Seller or the Buyer on 10 days written notice, if the transactions
contemplated hereby shall not have been consummated on or before 29th
February, 2008; provided, however, that the right to terminate this Agreement
pursuant to this §12.1(c) shall not be available to any party whose failure to
fulfill any obligation under this Agreement has been the cause of, or resulted
in, the failure of the consummation of the transactions contemplated hereby to
have occurred on or before the aforesaid date.

12.2      Effect of Termination.
Each party’s right of termination under §12.1 is in addition to any other
rights it may have under this Agreement or otherwise, and the exercise of a
right of termination will not be an election of remedies. If this Agreement is
terminated pursuant to §12.1, unless otherwise specified in this Agreement, all
further obligations of the parties under this Agreement will terminate;
provided, however, that if this Agreement is terminated by a party because of
the breach of this Agreement by the other party or because one or more of the
conditions to the terminating party’s obligations under this Agreement is not
satisfied as a result of the other party’s failure to comply with its
obligations under this Agreement, the terminating party’s rights to pursue all
legal remedies will survive such termination unimpaired. 

ARTICLE 13

MISCELLANEOUS

13.1      Entire Agreement.
This Agreement, including the Schedules hereto, and the other certificates,
agreements, and other instruments to be executed and delivered by the parties in
connection with the transactions contemplated hereby, constitute the sole
understanding of the parties with respect to the subject matter hereof and
supersede all prior oral or written agreements with respect to the subject
matter hereof.

13.2      Purchaser’s Solicitors.
The Seller acknowledges and agrees that the Buyer’s Solicitors have acted as
counsel only to the Buyer and that the Buyer’s Solicitors are not protecting the
rights and interests of any other Party and that the Seller has had the
opportunity to seek and was not prevented from seeking independent legal advice
before the execution and delivery of this Agreement and all other agreements,
certificates or instruments to be executed or delivered by the Seller pursuant
to or contemplated by this Agreement. If the Seller did not avail itself of the
opportunity to seek independent 

legal advice before signing this Agreement, the Seller did so
voluntarily without any undue pressure and agrees that such failure to obtain
independent legal advice will not be used by the Seller as a defence to the
enforcement by the Buyer of the obligations of the Seller under this Agreement
or such other agreements, certificates or instruments

13.3      Parties Bound by
Agreement; Successors and Assigns. The terms, conditions, and obligations of
this Agreement shall inure to the benefit of and be binding upon the parties
hereto and their respective successors and assigns.

13.4      Amendments and Waivers.
No modification, termination, extension, renewal or waiver of any provision
of this Agreement shall be binding upon a party unless made in writing and
signed by such party. A waiver on one occasion shall not be construed as a
waiver of any right on any future occasion. No delay or omission by a party in
exercising any of its rights hereunder shall operate as a waiver of such
rights.

13.5      Severability. If for
any reason any term or provision of this Agreement is held to be invalid or
unenforceable, all other valid terms and provisions hereof shall remain in full
force and effect, and all of the terms and provisions of this Agreement shall be
deemed to be severable in nature. If for any reason any term or provision
containing a restriction set forth herein is held to cover an area or to be for
a length of time which is unreasonable, or in any other way is construed to be
too broad or to any extent invalid, such term or provision shall not be
determined to be null, void and of no effect, but to the extent the same is or
would be valid or enforceable under applicable law, any court of competent
jurisdiction shall construe and interpret or reform this Agreement to provide
for a restriction having the maximum enforceable area, time period and other
provisions (not greater than those contained herein) as shall be valid and
enforceable under applicable law.

13.6      Attorney’s Fees.
Should any party hereto retain counsel for the purpose of enforcing, or
preventing the breach of, any provision hereof including, but not limited to,
the institution of any action or proceeding, whether by arbitration, judicial or
quasi-judicial action or otherwise, to enforce any provision hereof or for
damages for any alleged breach of any provision hereof, or for a declaration of
such party’s rights or obligations hereunder, then, whether such matter is
settled by negotiation, or by arbitration or judicial determination, the
prevailing party shall be entitled to be reimbursed by the losing party for all
costs and expenses incurred thereby, including, but not limited to, reasonable
attorneys’ fees for the services rendered to such prevailing party.

13.7      Counterparts. This
Agreement may be executed in one or more counterparts, each of which shall for
all purposes be deemed to be an original and all of which shall constitute the
same instrument.

13.8      Headings. The
headings of the sections and paragraphs of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction hereof.

13.9      Expenses. Except as
specifically provided herein, the Seller and the Buyer shall each pay all costs
and expenses incurred by it or on its behalf in connection with this Agreement
and the transactions contemplated hereby, including fees and expenses of its own
financial consultants, accountants, and counsel.

13.10      Notices. All
notices, requests, demands, claims, and other communications which are required
or may be given under this Agreement shall be in writing and shall be deemed to
have been duly given when received if by personal delivery, on the next business
day if by facsimile or other similar 

means of electronic communication or five business days after
such notice, request, demand, claim or other communication is sent, if sent by
registered or certified mail, return receipt requested, postage prepaid; and, in
any case, all such communications must be addressed to the intended recipient at
the address set forth on the first page of this Agreement. Any party may send
any notice, request, demand, claim, or other communication hereunder to the
intended recipient at the address set forth above using any other means, but no
such notice, request, demand, claim, or other communication shall be deemed to
have been duly given unless and until it actually is received by the intended
recipient. Any party may change the address to which notices, requests, demands,
claims, and other communications hereunder are to be delivered by giving the
other party notice in the manner herein set forth.

13.11      Governing Law. This
Agreement shall be construed in accordance with and governed by the laws of the
State of Nevada without giving effect to the principles of choice of law
thereof.

13.12      Arbitration. Any
dispute arising under or in connection with any matter related to this Agreement
or any related agreement shall be resolved exclusively by arbitration. The
arbitration shall be in conformity with and subject to the applicable rules and
procedures of the American Arbitration Association. All parties agree to be (1)
subject to the jurisdiction and venue of the arbitration in the State of Nevada,
(2) bound by the decision of the arbitrator as the final decision with respect
to the dispute and (3) subject to the jurisdiction of the Superior Court of the
State of Nevada for the purpose of confirmation and enforcement of any
award.

13.13      References, Etc.

(a)     
Whenever reference is made in this Agreement to any Article, Section, or
paragraph, such reference shall be deemed to apply to the specified Article,
Section or paragraph of this Agreement.

(b)     
Wherever reference is made in this Agreement to a Schedule, such reference shall
be deemed to apply to the specified Schedule attached hereto, which are
incorporated into this Agreement and form a part hereof. All terms defined in
this Agreement shall have the same meanings in the Schedules attached
hereto.

(c)      Any
form of the word “include” when used herein is not intended to be
exclusive (e.g., “including” means “including, without
limitation”).

13.14      No Strict Construction.
The language used in this Agreement will be deemed to be the language chosen
by the parties hereto to express their mutual intent, and no rule of strict
construction will be applied against any person.

13.15      No Third Party
Beneficiary Rights. No provision in this Agreement is intended or shall
create any rights with respect to the subject matter of this Agreement in any
third party.

13.16      Such Other Acts. The
parties hereto shall do all such things, and take such acts and execute such
documents as are necessary to give effect to the transactions contemplated
hereby.

13.17      Electronic Means.
Delivery of an executed copy of this Agreement by electronic facsimile
transmission or other means of electronic communication capable of producing a
printed copy will be deemed to be execution and delivery of this Agreement as of
the date first indicated above.

IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed on its behalf as of the date first indicated above.

	OXON LIFE SCIENCE LIMITED 	 
	 	  	 
	 	/s/ Lars Christiansen 	 
	 	  	 
	Per:	 	 
	 	Authorized Signatory 	 
	Name: 	Lars Christiansen 	 
	Title: 	Director 	 
	 	  	 
	 	  	 
	 	  	 
	 	  	 
	NEXTGEN BIOSCIENCE INC. 	 
	 	  	 
	 	/s/ Konstantinos Kardiasmenos 	 
	 	  	 
	Per: 		 
	 	Authorized Signatory 	 
	Name: 	Konstantinos Kardiasmenos 	 
	Title:	Director 	 

SCHEDULE A

ASSETS PURCHASED

The Assets purchased are comprised of the following and all
related intellectual and other property:

Technology

Use and ownership of patent application for the treatment of
cancer.

The patent application is an improved method for the
purification of undifferentiated stem cells from solid breast carcinomas that
are normally resistant to conventional therapies. Such stem cells are valuable
for identifying new tumour markers and novel therapeutic targets both for early
diagnosis and for targeted therapeutic strategies. 

Such therapeutic strategies are based on cytokine neutralizing
antibodies against interleukin-4 (IL-4) and interleukin-10 (IL-10) and
antibodies reactive with HMW-MAA which are found in high levels in stem cells
from solid breast carcinomas.

Trade Marks

None

Patent Applications

EPO P2039EP00 – Title: ““Method for inducing breast carcinoma
stem cell death” Filer: NextGen Bioscience Inc; Denmark’s Patent Office
submission # PA 2007 01846: December 22nd, 2007.

Copyright

None

Other Assets

None

SCHEDULE B

DISCLOSURE SCHEDULE

	1.1(f) 	Consents and Approvals Required: 
	 	 
	  	None 
	 	 
	3.7(d) 	Agreements Pertaining to use of Intellectual
      Property: 
	 	 
	  	None 

SCHEDULE C

ASSIGNMENT OF INTELLECTUAL PROPERTY

WHEREAS OXON LIFE SCIENCE LIMITED, a company
incorporated in Nevis, British West Indies and having an address at Donegan,
Zetlands, Nevis, St Kitts & Nevis, West Indies (the “Assignor”), is
the owner of all right, title and interest in and to all of the Assets, as such
term is defined in an Asset Purchase Agreement effective as of 31st
January, 2008 by and between the Assignor and NEXTGEN BIOSCIENCE INC.
(the “Assignee”);

     AND WHEREAS NEXTGEN BIOSCIENCE
INC., a company incorporated under the laws of State of Nevada and having a
business address at 4th Floor, 36 Spital Square, London, England E1
6DY, is desirous of securing the entire right, title and interest in and to the
Assets;

     NOW, THEREFORE, be it known that,
for good and valuable consideration, the sufficiency and receipt of which is
hereby acknowledged, we, as Assignor, have sold, assigned, transferred, and set
over, and do hereby sell, assign, transfer, and set over unto the Assignee or
its designees, and their lawful successors and assigns, our entire right, title,
and interest in and to the Assets.

     AND, WE HEREBY further covenant
and agree that we, as Assignor, will, without further consideration, communicate
with the Assignee, its successors and assigns, any facts known to us respecting
the Assets and testify in any legal proceeding, sign all lawful papers when
called upon to do so, execute and deliver all papers that may be necessary or
desirable to perfect the title to the Assets in said Assignee or designee, and
their successors and assigns, understanding that any expense incident to the
execution of such papers shall be borne by the Assignee, its successors and
assigns.

EXECUTED this 31st day of January, 2008.

IN TESTIMONY WHEREOF, We have hereunto set our hands.

OXON LIFE SCIENCE LIMITED

	 	/s/ Lars Christiansen 	 
	 	  	 
	Per: 		 
		Name: Lars Christiansen 	 
		Title: Director 	 

WITNESS:

On this 31st day of January, 2008, before me personally
appeared Lars Christiansen, who is known to me to be the individual who executed
the foregoing instrument on behalf of the Assignor and who acknowledged to me
that he/she executed the same and was duly authorized by the Assignor to do
so.

	Signed, Sealed and Delivered in the presence of: 	) 
	  	) 
	/s/ Graham May 	) 
	  	) 
	  	) 
	Witness (Signature) 	) 
	 	)
	Graham May 	) 
	Name (please print) 	) 
	  	) 
	13 Penningtons 	) 
	Address 	) 
	 	)
	Bishops Stortford,
      CM23 4LE, UK 	) 
	City, Province 	) 
	  	) 
	Lawyer 	  
	Occupation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]